Successful treatment with secukinumab in an <scp>HIV</scp> ‐positive psoriatic patient after failure of apremilast-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Successful treatment with secukinumab in an HIV ‐positive psoriatic patient after failure of apremilast

Published:2022-06-07 Issue:8 Volume:35 Page:
ISSN:1396-0296
Container-title:Dermatologic Therapy
language:en
Short-container-title:Dermatologic Therapy

Author:

Romita Paolo¹^ORCID,Foti Caterina¹,Calianno Gianluca¹^ORCID,Chiricozzi Andrea²³^ORCID

Affiliation:

1. Department of Biomedical Science and Human Oncology, Section of Dermatology University of Bari Bari Italy

2. Dermatologia, Dipartimento Scienze Mediche e Chirurgiche Fondazione Policlinico Universitario A. Gemelli IRCCS Rome Italy

3. Dermatologia, Dipartimento Universitario di Medicina e Chirurgia Traslazionale Università Cattolica del Sacro Cuore Rome Italy

Publisher

Hindawi Limited

Subject

Dermatology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/dth.15610

Reference10 articles.

1. HIV-associated psoriasis: pathogenesis, clinical features, and management

2. Psoriasis: Which therapy for which patient

3. The unforeseen during biotechnological therapy for moderate‐to‐severe psoriasis: How to manage pregnancy and breastfeeding, infections from Mycobacterium tuberculosis , hepatitis B virus, hepatitis C virus, and HIV , surgery, vaccinations, diagnosis of malignancy, and dose tapering

4. HIV‐associated psoriasis: Epidemiology, pathogenesis, and management

5. Apremilast as therapeutic option in a HIV positive patient with severe psoriasis

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The use of secukinumab in patients with chronic infections;JEADV Clinical Practice;2024-01-20

2. Biologic Therapies in HIV/AIDS Patients with Inflammatory Diseases: A Systematic Review of the Literature;AIDS Patient Care and STDs;2023-05-01

3. Apremilast/secukinumab;Reactions Weekly;2022-09-03

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3